SCHEMBL4735233

SCHEMBL4735233

OCCn1cc(-c2ccccc2)[nH]c1=S

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.57
KDM4E B2RXH2 7/20 0.57
MEN1 O00255 3/20 0.57
RECQL P46063 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
RAB9A P51151 7/20 0.51
GAA P10253 6/20 0.45
MAPT P10636 7/20 0.43
GFER P55789 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPK1 P28482 2/20 0.43
MCL1 Q07820 1/20 0.43
NPC1 O15118 4/20 0.42
HPGD P15428 1/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
APOBEC3G Q9HC16 2/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10899145 0.80 ERCC1 (0.46) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4786062 0.79 RAB9A (0.50) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4736170 0.78 KMT2A (0.58) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4738890 0.77 KMT2A (0.51) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4738664 0.76 KMT2A (0.50) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4739350 0.76 KMT2A (0.50) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4739765 0.75 RAB9A (0.46) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL4737872 0.75 KMT2A (0.51) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL259629 0.73 RAB9A (0.59) KMT2AKDM4EMEN1RECQLRXFP1
SCHEMBL3159586 0.73 RAB9A (0.59) KMT2AKDM4EMEN1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008085008-A1 T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2008-07-17 WO claimed
WO-2008085008-A1 T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE (KR) 2008-07-17 WO disclosed
US-4620009-A CATALYTIC REDUCTION OF IMIDAZOLIN ONE DERIVATIVE CYANAMID AGRICULTURAL DE PUERTO RICO, INC. (US) 1986-10-28 US disclosed
US-4370482-A Synthesis of tetramisole, levamisole and their derivatives AMERICAN CYANAMID CO. (US) 1983-01-25 US disclosed
US-4314066-A PREPARATION OF 1-(2-SUBSTITUTED ETHYL)-4-PHENYL-2-IMIDAZOLIDONES AND IMIDAZOLIDINE-2-THIONESC HYDROGENATION, CHIRAL CATALYST, HYDROLYSIS, SULFURIZATION AMERICAN CYANAMID CO. (US) 1982-02-02 US disclosed
US-4310672-A Synthesis of intermediates for tetramisole, levamisole and their derivatives AMERICAN CYANAMID CO. (US) 1982-01-12 US disclosed
US-4139707-A ANTHELMINTICS AMERICAN CYANAMID COMPANY (US) 1979-02-13 US disclosed
US-4090025-A ALKOXYETHYL-PHENYL-IMIDAZOLIN-2-ONES OR 2-IMIDAZOLIDONES OR IMIDAZOLIDINE-2-THIONES AMERICAN CYANAMID COMPANY (US) 1978-05-16 US disclosed
US-4087611-A CHEMICAL INTERMEDIATES AMERICAN CYANAMID COMPANY (US) 1978-05-02 US disclosed